Article R1211-11
…tion or insemination, or to the establishment or organisation authorised to store tissues and their derivatives or cell therapy preparations in application of article L. 1243-1.
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 4891–4900 of 13025 articles for “Art. Euronext Harmonised Market Rules — derivatives”
…tion or insemination, or to the establishment or organisation authorised to store tissues and their derivatives or cell therapy preparations in application of article L. 1243-1.
Manufacturers of in vitro diagnostic medical devices may import or export tissues, their derivatives and cells from the human body, whatever their level of processing, when these products are intended…
…le L. 5121-20, 14°; 9° For one of the pharmacists mentioned in article L. 5125-33, disregarding the rules applicable to electronic commerce in medicinal products set out in Chapter Va of Title II of B…
…lth defines the procedures for granting aid to those responsible for placing prevention kits on the market, as well as the maximum price for placing on the market and the specifications describing the…
…import authorisation are identical to those of the proprietary medicinal product which has obtained marketing authorisation in France, except in that they include : 1° The addition, in addition to the…
…nt-Martin, Saint-Pierre-et-Miquelon and Wallis-et-Futuna, and in sectors where supply conditions or market structures limit the free play of competition, the Government may, after receiving the public…
Any wholesale distributor, where he is not the marketing authorisation holder, who imports a veterinary medicinal product from another Member State shall inform the marketing authorisation holder and…
The marketing authorisation may impose one or more of the following conditions, which must be mentioned in the risk management system: 1° The implementation of measures to ensure the safe use of the m…
Studies on veterinary medicinal products that already have a marketing authorisation" within the meaning of 6° of article L. 5141-16, hereinafter referred to as "post-authorisation studies", means stu…
The importation, by any organisation whatsoever, of a labile blood product or a plasma paste, for direct therapeutic use or intended for the preparation of health products, is subject to authorisation…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More